Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4587541 | 0.94 | SIGMAR1 (0.43) | SIGMAR1MAOA | |
| SCHEMBL8824531 | 0.86 | SIGMAR1 (0.45) | SIGMAR1MAOA | |
| SCHEMBL9871271 | 0.84 | EPHX1 (0.50) | SIGMAR1MAOA | |
| SCHEMBL7929689 | 0.82 | CSNK1E (0.54) | — | |
| SCHEMBL27460034 | 0.81 | CSNK1E (0.45) | SIGMAR1MAOA | |
| SCHEMBL6049243 | 0.80 | EPHX1 (0.50) | SIGMAR1MAOA | |
| SCHEMBL24108632 | 0.78 | EPHX1 (0.48) | SIGMAR1MAOA | |
| SCHEMBL28258282 | 0.77 | SIGMAR1 (0.43) | SIGMAR1MAOA | |
| SCHEMBL8673059 | 0.76 | EPHX1 (0.43) | SIGMAR1MAOA | |
| SCHEMBL11693551 | 0.76 | TRPA1 (0.46) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7737275-B2 | Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2010-06-15 | — | — | US | disclosed |
| US-20060293520-A1 | Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293520-A1 | Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils | HPRT1, TH, METTL3 | SIGMAR1 535/4885MAOA 249/4885MAOB 1050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.